Benefits of new retinal implant clear to see, but experts remain divided
This article was originally published in Clinica
Executive Summary
Results from a study of an experimental retinal transplant have suggested that the technique could improve the vision of patients with chronic eye disease. The phase II trial was conducted in 10 patients with retinitis pigmentosa (RP) or age-related macular degeneration (AMD) with 20/200 vision or worse. A person with visual acuity of 20/200 or below is considered legally blind in the US. 20/20 vision is considered nominal performance.